U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Partnerships: Enhancing Science Through Collaborations With FDA
  4. FDA Memoranda of Understanding
  5. Academic MOUs
  1. Partnerships: Enhancing Science Through Collaborations With FDA

Academic MOUs

Academic MOUs

MOU No. Purpose Parties FDA Lead Center or
Office/Contact
Effective Date Expiration
Date
225-93-2001 IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology. Illinois Institute of Technology CFSAN
Don Zink
(240) 402-1693
09-03-1993 Indefinite
225-02-8001 Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. University of Maryland OC
Eileen Parish
(301) 796-8522
09-04-2002 Indefinite
225-03-6000 Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. University of Houston CDRH
Michelle Chenault
(240) 276-3815
03-29-2003 Indefinite
225-03-8002 Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. Virginia Polytechnic Institute OC
Eileen Parish
(301) 796-8522
03-13-2003 Indefinite
225-03-8003 Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. Howard University OC
Eileen Parish
(301) 796-8522
05-29-2003 Indefinite
225-05-6000 To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine." Brigham and Women's Hospital CDRH
Anindita Saha
(301) 796-2537
Mimi Nguyen
(301) 796-4125
05-09-2006 Indefinite
225-05-6001 Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information. Duke University and Duke University Health System, Inc. CDRH
Annindita Saha
(301) 796-2537
Mimi Nguyen
301-796-4125
09-18-2006 Indefinite
225-07-6001 Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine. Amended to change POC and termination date. Stanford University CDRH
Anindita Saha
(301-796-2537
Mimi Nguyen
301-796-4125

07-12-2012
Revised on
05-11-2016

Indefinite
225-07-8005 To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process. Duke University OC
Melissa Robb
(301) 827-1516
09-22-2007 Indefinite
225-07-8008-1 To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology.  Replaced MOU #s 225-07-8008 and 225-02-8000. John Hopkins University OC
Eileen Parish
(301) 796-8522
05-20-2015 05-20-2020
225-07-8405 Forms the basis for development of scientific collaborations, outreach and educational
initiatives and intellectual partnerships between FDA and USM.
University System of Maryland Office of the Chief Scientist 04-02-2018 Indefinite
225-11-0024 Establishes a collaborative framework between the FDA and the University of Florida through a variety of programs, including collaborative education and research. Term Extension Modification. University of Florida CDER
Ryan Chatman
(301) 796-2106
09-21-2011 09-19-2021
225-12-0004 Establishes the collaboration between The United States Food and Drug Administration (FDA) and Thomas Jefferson University to share interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Program. Time Extension Amendment The Thomas Jefferson University CDER
Ryan Chatman
(301) 796-2106
12-09-2011 12-09-2021
225-12-0011 Forms the basis for the initial relations between FDA and the University of Hawaii, College of Pharmacy for sabbaticals, research and scientific education University of Hawaii Hilo, College of Pharmacy OMH
Richardae Araojo
(301) 796-8000
03-30-2012 Indefinite
225-12-0012 Forms the basis for the initial relations between FDA and the University of Hawaii for sabbaticals, research and scientific education. University of Hawaii at Manoa, Office of Public Health Studies OMH
Richardae Araojo
(301) 796-8000
04-24-2012 Indefinite
225-12-0018 Establishes the terms between the Food and Drug Administration (FDA) and Stanford University (Stanford) to promote scientific progress through exchange of scientific capital in diverse fields of science that affect human and animal health and medicine. Stanford University CDER
Gerald J. Dal Pan, MD, MHS
301-796-2380
05-17-2012 Indefinite
225-12-0029 Forms the basis for the initial relations between FDA and Meharry Medical College (Meharry) for sabbaticals, research and scientific education. Meharry Medical College OMH
Richardae Araojo
(301) 796-8000
06-21-2012 Indefinite
225-13-002 This MOU establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research.
 
Harvard T.H. Chan School of Public Health CDER
Scott N. Goldie
General Health Scientist
(301) 796-2055
 
1-18-2018 1-18-2021
225-13-0025 Establishes terms of collaboration between FDA and the University of Hamburg for development of scientific collaborations, outreach and educational initiatives, and intellectual partnerships. University of Hamburg CFSAN
Eric Brown, PhD
(240) 402-2020
09-05-2013 Indefinite
225-14-007 This Memorandum of Understanding (MOU) states the mutual intention of the parties to seek opportunities for collaboration and to promote shared interests in various science-based academic initiatives, fellowships, and student internships. York College of the City University of New York OMH
Richardae Araojo
(301) 796-8000
02-20-2014 Indefinite
225-14-014 Promoting scientific progress through exchange of scientific capital in the areas of public health and regulatory research. Regents of the University of Minnesota CDER
Mark Lauda
(301) 796-0381
09-04-2014 09-03-2019
225-15-002 Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships. University of Massachusetts Amherst ORA/WEAC
Brian L. Baker
(871) 856-9701
09-12-2014 09-11-2019

225-15-006

Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships. Morehouse School of Medicine OMH
Richardae Araojo
(301) 796-8000
12-22-2014 Indefinite
225-15-013
 
Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs. This was amended to extend the termination date to June 30, 2021. University of California at San Diego CDER 

06-30-2012
Revised on
05-08-2018

06-30-2021
225-16-001
Identify indicators of cardiovascular risk, predict adverse cardiovascular events associated with therapeutic interventions, and improve the clinical utility of biomarker technologies as diagnostic and assessment tools that facilitate developing safer and more effective cardiovascular therapies, diagnostic and assessment tools.
Duke University Cardiac Safety Research Consortium Norman Stockbridge, MD, PhD
(301) 796-9841
10-28-2015 Indefinite
225-16-005
Establish opportunities for scientific and medical exchange between the FDA scientific staff and the University’s science students and academicians through collaborative research and training.
University of Rochester OCS
Eileen Parish, M.D.
(301) 796-8522 
12-14-2015 12-14-2020
225-16-006 To establish a mutually acceptable agreement between FDA and Cornell that will provide for collaboration on the development and delivery of training to FDA and State, Local, Tribal, and Territorial inspection personnel. Cornell University ORA
Patricia L. Alcock
Director, Division of Human Resource Development
301-796-4299
12-18-2015 12-18-2020
225-16-014 Promote scientific capital, training, research, training, and research expertise. Information sharing in regulatory science research, training, sabbaticals, postdoctoral, recruitment opportunities, fellowships, and student internships. Rutgers University ORA
Paula Davy
(718) 340-7942
Nazmul Hassan
(718) 62-5707
01-26-2016 01-25-2021
225-16-021 Establishes terms for collaboration through a variety of programs, e.g., research, graduate student training, and exchange of scientists, exchange of staff, sabbaticals, post-doctoral fellowships, and student interns. Worcester Polytechnic Institute CDER
Gerald J. Dal Pan, MD, MHS, CDER
301-796-2380
08-25-2016 Indefinite
225-16-023 Promote share interests in collaborative education and research. Virginia Commonwealth University Padmaja Mummaneni, Ph.D.
301-796-2027
08-16-2016 08-15-2021
225-16-030 To facilitate existing and new mutually agreed upon programs and activities to promote shared interests, which can be pursued through a variety of programs including collaborative education and research. The University of Alabama’s School of Medicine, Department of Neurology CDER
Padmaja Mummaneni, Ph.D.
10902 New Hampshire Avenue, White Oak Building 51
Silver Spring, MD
(301) 796-2027
12-06-2016 12-06-2021
225-17-002 Shared interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Programs.  Replaced MOU 225-11-0006. University of California San Francisco CDER
Padmaja Mummaneni,
301-796-2027
10-9-2016 10-08-2021
225-17-010 This MOU establishes the terms for collaboration between FDA and HCV-TARGET to promote shared interests, which can be pursued through a variety of programs including collaborative
research.
HCV-TARGET, the University of Florida, and the University of North Carolina at Chapel Hill CDER
Poonam Mishra, M.D., MPH
Division Director (Safety)
Division of Antiviral Products
Office of New Drugs
02-16-2017 02-16-2020
225-17-017 FDA and GUMC share interests In promoting scientific progress through the exchange of scientific capital in the diverse disciplines that directly and Indirectly affect human and animal health and medicine. Georgetown University Medical Center Khaled Bouri, Ph.D.
Office of Regulatory Science and Innovation, Office of the Chief Scientist
301-796-8476
6-9-2017 6-9-2022
225-17-024 To facilitate existing and new mutually agreed upon programs and activities and establish the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research. University of Washington School of Pharmacy

CDER
Padmaja Mummaneni, PhD
(301) 796-2027

09-26-2017 09-26-2022
225-17-026 Promote scientific progress through exchange of scientific capital
to enhance the assessment of safety and efficacy of FDA-regulated products through joint educational and training fellowship programs.
Duke University CDER
Padmaja Mummaneni, PhD
301-796-2027 
 
08-03-2017 08-02-2022
225-17-032 This MOU establishes terms for collaboration to promote shared interests, which may be pursued through a variety of programs including collaborative education and research. University of Utah CDER
Padmaja Mummaneni
10903 New Hampshire Avenue
FDA White Oak Building 51, Room 2164
Silver Spring, MD 20993-0002
Telephone Number: 301-796-2027
10-18-2017 10-18-2022
225-17-033 This MOU establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research. University of North Carolina at Chapel Hill CDER
Scott Goldie, Ph.D.
10903 New Hampshire Avenue
Building 21 Room 3557
Silver Spring, MD 20993
(301) 796-2055
9-14-2017 Indefinite
225-17-034 The collaborative framework this MOU provides will facilitate existing and new mutually agreed upon programs and activities and establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research. Stanford University School of Medicine, Department of Bioengineering CDER
Padmaja Mummaneni, PhD
10903 New  Hampshire Avenue White Oak Building 51, Room 2164
Silver Spring, MD 20993-0002
(301) 796-2027
10-06-2017 10-06-2022
225-17-035 The parties want to collaborate on biomedical engineering projects of importance to the regulatory science priorities at CDRH. Zhang Bioengineering Laboratory, Clemson University CDRH
Edward Margerrison, Ph.D., Director
Office of Science and Engineering Laboratories
Edward.Margerrison@fda.hhs.gov
09-15-2017 09-15-2022
225-17-036 This MOU and the collaborative framework it provides will facilitate existing and new mutually agreed upon programs and activities, consortia and consensus development between the parties and establishes the terms for collaboration to promote shared interests. Rutgers School of Health Professions CDER
Padmaja Mummaneni, Ph.D.
Consumer Safety Officer
10903 New Hampshire Avenue White Oak Building 51,
Room 2164
Silver Spring, MD 20993
(301) 796-2027
10-16-2017 10-16-2022
225-17-037 This MOU establishes the terms for collaboration to promote FDA and University of Pittsburgh’s shared interests, which can be pursued through a variety of programs. University of Pittsburgh CDER
Padmaja Mummaneni, PhD
(301) 796-2027
01-18-2018 01-18-2023
225-18-001 This MOU establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education and research. Vanderbilt University Medical Center (VUMC) CDER
Scott N. Goldie, Ph.D.
Special Assistant for the Office of Biostatistics
10903 New Hampshire Avenue,
Building 21 Room 3577
Silver Spring, MD 20993
10-30-2017 Indefinite
225-18-004 Establishes terms of collaboration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas. University of Maryland, Baltimore County CDER
Dr. Kurt Brorson
(301) 796-2193
07-25-2003 Indefinite
225-18-013 Establishes a framework for this collaboration to enhance mutual cybersecurity and technology related interactions in education and research. Montgomery College Office of the Chief Information Officer
Craig Taylor
301-796-8696
03-28-2018 Indefinite
225-18-015 Promote shared interests in various science-based academic initiatives, fellowships, internships, sabbaticals, research and scientific education. Yale University Office of Minority Health
CAPT Richardae Araojo
301-796-1152 
03-28-2018 Indefinite
225-18-016 Shared interests in promoting scientific progress through exchange of scientific capital in public health, epidemiology and research. State University of New York at Buffalo Office of Minority Health/OC
Yeruk (Lily) Mulugeta
301-796-3162
05-14-2018 05-13-2023
225-18-021 Promotes scientific progress through exchange of scientific capital in clinical pharmacy and pharmacology training, research programs, clinical research in pharmacotherapy, biopharmaceutics, clinical pharmacology and translational science. University of Georgia CDER 08-28-2018 08-27-2023
225-18-029 Collaborate on biomedical engineering projects of importance to the regulatory science priorities at CDRH. The parties have an interest in better understanding the bioengineering performance of many regulated medical and surgical devices. University of Kentucky CDRH
Edward Margerrison, Ph.D.
09-18-2018 09-18-2023
225-19-003 The purpose of MOU 225-19-003 is to establish a framework for collaborative educational, research and training opportunities.  The joint efforts will be undertaken to develop collaborative research and training programs as permitted under appropriate statutory authority.
 
Massachusetts Institute of Technology OC
Sean Khozin, MD, MPH
01-30-2019 01-30-2024
 

Sub-Topic Paragraphs

Other Categories

Domestic MOUs

Agreements between FDA and other domestic government entities, including federal, state, and local agencies.